Prosecution Insights
Last updated: April 19, 2026

Evelo Biosciences Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
2
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18285890 PHARMACEUTICAL COMPOSITION CONTAINING BACTERIA JACKSON-TONGUE, LAKIA J 1645 Non-Final OA Oct 06, 2023
18034202 COMPOSITIONS COMPRISING SPIRULINA COMPONENTS ARIANI, KADE 1651 Non-Final OA Apr 27, 2023
18027003 SOLID DOSAGE FORMS OF BACTERIA JACKSON-TONGUE, LAKIA J 1645 Non-Final OA Mar 17, 2023
17780819 METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA EIX, EMILY FAY 1653 Final Rejection May 27, 2022
17632449 METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA SHAHNAN SHAH, KHATOL S 1645 Final Rejection Feb 02, 2022
17613341 METHODS AND COMPOSITIONS FOR ANAEROBIC BACTERIAL FERMENTATION MOAZZAMI, NAGHMEH NINA 1652 Non-Final OA Nov 22, 2021

Managing Evelo Biosciences Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month